| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.26 | 0.1 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |